î Novo Nordisk A/Sã®çŸåšã®è²¡åã¹ã³ã¢ã¯9.20ã§ãã ãã®è²¡åç¶æ³ã¯å®å®ã§ãã ãŸããäºæ¥å¹çã¯é«ãã§ãã ææ°ååæã®å£²äžé«ã¯12.21Bã§ãåå¹Žåææ¯å¢å ã®4.55%ã§ãããäžæ¹ãçŽå©çã¯åå¹Žåææ¯å¢å ã®18.92%ãšãªããŸããã
î Novo Nordisk A/Sã®çŸåšã®ããªã¥ãšãŒã·ã§ã³ã¹ã³ã¢ã¯9.10ã§ãã çŸåšã®PERã¯9.14ã§ãçŽè¿é«å€50.57ã453.39%äžåããçŽè¿å®å€8.73ã4.45%äžåã£ãŠããŸãã
î Novo Nordisk A/Sã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯6.31ã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯48.52ã§ãæé«ã¯65.00ãæäœã¯40.00ã§ãã
î Novo Nordisk A/Sã®çŸåšã®äŸ¡æ Œã¢ã¡ã³ã¿ã ã¹ã³ã¢ã¯2.72ã§ãã çŸåšãæ ªäŸ¡ã¯æµæç·40.21ãšæ¯æç·37.38ã®éã§æšç§»ããŠãããã¬ã³ãžçžå Žã§ã®ã¹ã€ã³ã°ãã¬ãŒãã«é©ããŠããŸãã
î Novo Nordisk A/Sã®çŸåšã®æ©é¢æè³å®¶ææ ªã¹ã³ã¢ã¯3.00ã§ãã ææ°ã®æ©é¢æè³å®¶ä¿ææ¯çã¯9.89%ã§ãåååææ¯å¢å 7.16%ã§ãã
î Novo Nordisk A/Sã®çŸåšã®ãªã¹ã¯è©äŸ¡ã¹ã³ã¢ã¯6.60ã§ãã å瀟ã®ããŒã¿å€ã¯0.79ã§ãã ããã¯ãäžæçžå Žã§ã¯æ ªäŸ¡ãåžå Žå
šäœïŒææ°ïŒãäžåãåŸåãããäžæ¹ã§ãäžèœçžå Žã§ã¯äžèœå¹
ãéå®çãšãªãåŸåã瀺ããŠããŸãã